{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:17:15Z","timestamp":1775495835328,"version":"3.50.1"},"reference-count":17,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T00:00:00Z","timestamp":1350432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>The grey zone (<jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content>; 45\u201354 <jats:styled-content style=\"fixed-case\">CGG<\/jats:styled-content> repeats in the <jats:italic><jats:styled-content style=\"fixed-case\">FMR1<\/jats:styled-content><\/jats:italic> gene) is considered a normal allele; however, several studies have found a high frequency of <jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content> in movement disordered populations. Here, we describe neurological features of fragile X\u2010associated tremor\/ataxia syndrome (<jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content>) in two carriers of <jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content> alleles, although <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content> has been defined as occurring only in premutation carriers (55\u2013200 <jats:styled-content style=\"fixed-case\">CGG<\/jats:styled-content> repeats). Both patients had family members who had premutation and were diagnosed with <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content>. The presence of relatively high <jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content> alleles with elevated fragile X mental retardation 1 mRNA (<jats:italic><jats:styled-content style=\"fixed-case\">FMR1<\/jats:styled-content><\/jats:italic>\u2010<jats:styled-content style=\"fixed-case\">mRNA<\/jats:styled-content>) combined with a family history of <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content> that may represent a facilitating genetic background for <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content> are the factors that led to the presence of <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content> in these individuals with a <jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content> allele. Further research into clinical involvement of <jats:styled-content style=\"fixed-case\">GZ<\/jats:styled-content> alleles is recommended and the definition of <jats:styled-content style=\"fixed-case\">FXTAS<\/jats:styled-content> may require revision.<\/jats:p>","DOI":"10.1111\/cge.12026","type":"journal-article","created":{"date-parts":[[2012,9,26]],"date-time":"2012-09-26T01:20:58Z","timestamp":1348622458000},"page":"74-77","source":"Crossref","is-referenced-by-count":49,"title":["Fragile X\u2010associated tremor\/ataxia syndrome (<scp>FXTAS<\/scp>) in grey zone carriers"],"prefix":"10.1111","volume":"84","author":[{"given":"Y","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Neurology Dalian Municipal Friendship Hospital  Dalian PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TI","family":"Winarni","sequence":"additional","affiliation":[{"name":"Center for Biomedical Research Faculty of Medicine Diponegoro University  Semarang Central Java Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology University of California Davis School of Medicine  Sacramento CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Medicine University of California Davis School of Medicine  Sacramento CA USA"},{"name":"MIND Institute University of California Davis School of Medicine  Sacramento CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RJ","family":"Hagerman","sequence":"additional","affiliation":[{"name":"MIND Institute University of California Davis School of Medicine  Sacramento CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.1.127"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/374321"},{"issue":"8","key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2310\/JIM.0b013e3181be329a","article-title":"Molecular pathogenesis of fragile X\u2010associated tremor\/ataxia syndrome","volume":"57","author":"Raske C","year":"2009","journal-title":"J Investig Med"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01275.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh535"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/10.14.1449"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.043950"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24021"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e3181c35f25"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1086\/420700"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200105000-00010"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1261\/rna.280807"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3182064362"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21252"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp479"},{"key":"e_1_2_5_17_1","unstructured":"GrecoC TassoneF JacquemontS et al. Intranuclear neuronal inclusions in two female carriers of the fragile X premutation. Am J Hum Genetics 53rd Annual Meeting Los Angeles CA USA2003; 73(suppl 5) A2452:586."},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000269781.10417.7b"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcge.12026","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cge.12026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T15:45:40Z","timestamp":1700667940000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cge.12026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,17]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/cge.12026"],"URL":"https:\/\/doi.org\/10.1111\/cge.12026","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,17]]}}}